Tislelizumab Combined With Chemotherapy (CAPOX) in the Perioperative Treatment of MSI-H/dMMR Stage II or III Colorectal Cancer
Condition(s):MSI-H Colorectal Cancer; Tislelizumab; Oxaliplatin; CapecitabineLast Updated:May 9, 2023Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):MSI-H Colorectal Cancer; Tislelizumab; Oxaliplatin; CapecitabineLast Updated:May 9, 2023Not yet recruiting
Condition(s):Carpal Tunnel Syndrome; Charcot-Marie-Tooth Disease; Inherited Peripheral NeuropathyLast Updated:March 15, 2018Completed
Condition(s):Peripheral Arterial Disease; Intermittent ClaudicationLast Updated:August 21, 2018Completed
Condition(s):Atrioventricular Block; Left Bundle Branch Area PacingLast Updated:February 22, 2019Unknown status
Condition(s):Acquired Coagulation Factor DeficiencyLast Updated:February 11, 2011Completed
Condition(s):Prostate CancerLast Updated:July 29, 2020Unknown status
Condition(s):Reperfusion Injuries, MyocardialLast Updated:June 7, 2019Completed
Condition(s):AnalgesiaLast Updated:July 6, 2017Completed
Condition(s):HysterectomyLast Updated:April 3, 2019Suspended
Condition(s):Cataract; Lens OpacitiesLast Updated:July 20, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.